Based on the provided data, I'll analyze whether MMC is overvalued through multiple perspectives.
Valuation Analysis
MMC currently trades at $220.83 with a consensus price target of $235.55, suggesting a potential upside of 6.7%. The stock has underperformed both the S&P 500 (+22.8%) and XLF (+31.8%) over the past 52 weeks.
Growth & Performance
MMC reported strong Q4 2024 earnings with adjusted EPS of $1.87, beating estimates and showing 11% year-over-year growth. The company's consolidated revenues grew 9.4% year-over-year to $6.1 billion.
Analyst Consensus
Among 22 analysts covering MMC, the consensus is "Hold" with 4 Strong Buys, 2 Moderate Buys, 14 Holds, 1 Moderate Sell, and 1 Strong Sell. The mean price target of $235.55 implies modest upside potential.
Based on these factors, MMC appears fairly valued rather than overvalued, considering its strong earnings growth, market-leading position in insurance brokerage, and stable business model, despite recent underperformance against broader market indices.